Integrating Reminiscence Technology Into Exercise Programs in Subacute Care

February 14, 2023 updated by: Bruyere Research Institute
This study evaluates the feasibility of a randomized controlled trial to evaluate the impact of motivating reminiscence-based therapy on exercise adherence, mood and physical health within a subacute rehabilitation population. The jDome BikeAround technology displays user-specified Google Earth images onto a domed screen as the user pedals on a stationary bike, which fosters the experience of bicycling through that given environment. Participants will use the technology for 12 weeks during their regularly scheduled therapy sessions.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Adherence to physical activity in older adults and those in a low-intensity rehabilitation program is important with respect to achieving the demonstrated benefits in mobility, physical function and overall health maintenance. Physical activities that incorporate motivational strategies can improve long-term adherence to therapy programs. The jDome BikeAround technology is one example, as it involves reminiscence therapy coupled with stationary bicycling. Participant's are able to visit any familiar locations or places they have wished to visit, thus providing a positive and interactive experience as they engage in physical activity.

Participants will be enrolled for a total of 12 weeks. They will have three 10 minute weekly sessions with the jDome BikeAround during their regularly scheduled therapy sessions. Feasibility will be evaluated by participant recruitment, program completion, rate of adverse events and staff acceptance.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Canada
    • Ontario
      • Ottawa, Ontario, Canada, K1R 7A5
        • Recruiting
        • Saint-Vincent Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Admitted to the LIR (Low-intensity rehabilitation) or CMP (complex medical program) unit/floor where the research study is being conducted. Of note, both units receive low intensity rehabilitation services at baseline.
  • Participants capable of providing informed consent or have a SDM capable of providing consent on their behalf
  • Sufficient visual abilities to observe images on the domed screen
  • Able to comprehend and communicate in English or French
  • Minimum height requirement of 5'2" or 157cm in order to successfully fit the BikeAround system's stationary bike.

Exclusion Criteria:

  • Physical limitations (as determined by the SVH healthcare/physiotherapy team) that prevent use of the jDome BikeAround. This includes:
  • 1) Inability to coordinate/move lower limbs effectively to complete pedaling task
  • 2) The pedaling exercise causes discomfort/pain greater than expected with physical activity
  • 3) Medical treatment prevents usage of the system (i.e. continuous ventilatory needs for patients admitted within the CMP unit)
  • Cognitive impairment (as determined by the SVH healthcare/physiotherapy team) that prevent use of the jDome BikeAround, such as:
  • 1) Inability to sustain attention to focus on pedaling task
  • 2) Inability to follow one-step commands.
  • Known behavioral abnormalities (e.g. overly aggressive behavior) that in the opinion of the clinical care team might impede any meaningful participation in the project
  • Those who are in the opinion of, the attending physician or clinical team, too unwell to participate in the project

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Reminiscence-based physical therapy
Participants will use the reminiscence-based technology (jDome BikeAround) for 10-minute sessions for three times per week during the 12 week study enrolment period.
Other: Motivating reminiscence physical therapy
The jDome BikeAround system involves participants using a stationary bike while their selected location is displayed in front of them on a domed projector screen using Google Street View. Using pedals on the bike they can propel themselves down the street, steer and change direction as they wish.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant Recruitment
Time Frame: Baseline
Determine the feasibility of a future randomized controlled trial to evaluate the impact of the jDome BikeAround system on exercise adherence, mood and physical health within a subacute rehabilitation population. Feasibility will be determined by the ability to recruit 60 participants (based on the average number of patients admitted to the rehab units).
Baseline
Number of participants retained
Time Frame: Week 12
Determine the feasibility of a future randomized controlled trial to evaluate the impact of the jDome BikeAround system on exercise adherence, mood and physical health within a subacute rehabilitation population. Feasibility will be determined by the number of sessions participants attended, out of the total number of sessions offered.
Week 12
Rate of adverse events
Time Frame: Week 12
The number of adverse events experienced by participants related to the use of the jDome BikeAround will be monitored to evaluate the feasibility of a future randomized controlled trial using this technology.
Week 12
Staff Acceptance
Time Frame: Week 12
Staff Acceptance will be determined by measuring the number of sessions staff assign participants to use the jDome BikeAround, out of their total number of therapy sessions (I.e. total sessions assigned to use jDome BikeAround out of total therapy sessions which is 3 weekly sessions x 12 weeks).
Week 12

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Endurance
Time Frame: Total distance (meters) will be measured after each participant session (10 minutes) using the jDome BikeAround. This will occur 3 times per week throughout study duration for 12 weeks
Total distance (meters) travelled during each jDome BikeAround therapy bike session.
Total distance (meters) will be measured after each participant session (10 minutes) using the jDome BikeAround. This will occur 3 times per week throughout study duration for 12 weeks
Mood changes
Time Frame: Weekly after a jDome BikeAround session (for 12 weeks)
Participant mood changes will be measured following their jDome BikeAround session using The Face Scale developed by Lorish and Maisiak (1986)
Weekly after a jDome BikeAround session (for 12 weeks)
Functional Independence Measure (FIM score)
Time Frame: Baseline, week 6, week 12
Standardized measure of disability used in rehabilitation populations. Measure evaluating 18 functional tasks on a scale of 1 (total care) to 7 (independent). Maximum 126 (best) and minimum is 18 (worst).
Baseline, week 6, week 12
Satisfaction using jDome BikeAround - Participants
Time Frame: Baseline, week 6, week 12
This measure will be assessed using semi-structured interviews
Baseline, week 6, week 12
Satisfaction using jDome BikeAround - Staff
Time Frame: Baseline, week 6, week 12
This measure will be assessed using online surveys for rehabilitation staff. 5-point scale from "strongly disagree, disagree, neutral, agree, strongly agree"
Baseline, week 6, week 12
Emotional Impact
Time Frame: Baseline, week 6, week 12
This measure will be assessed using semi-structured interviews with participants. This will assessed depending on participant verbal responses, not using any particular scale.
Baseline, week 6, week 12
Impact on overall therapy experience - Participants
Time Frame: Baseline, week 6, week 12
This measure will be assessed using semi-structured interviews with participants
Baseline, week 6, week 12
Impact on overall therapy experience - Staff
Time Frame: Baseline, week 6, week 12
This measure will be assessed using online surveys for rehabilitation staff. 5-point scale from "strongly disagree, disagree, neutral, agree, strongly agree"
Baseline, week 6, week 12
Ease of instruction - Participants
Time Frame: Baseline, week 6, week 12
This measure will be assessed using semi-structured interviews with participants
Baseline, week 6, week 12
Ease of instruction - Staff
Time Frame: Baseline, week 6, week 12
This measure will be assessed using online surveys for rehabilitation staff. 3 questions graded on a 5-point scale from "strongly disagree, disagree, neutral, agree, strongly agree"
Baseline, week 6, week 12

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Bruyere Research Institute

Collaborators

Bruyere Academic Medical Organization

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

July 1, 2023

Primary Completion (Anticipated)

April 1, 2024

Study Completion (Anticipated)

April 1, 2024

Study Registration Dates

First Submitted

April 28, 2022

First Submitted That Met QC Criteria

May 16, 2022

First Posted (Actual)

May 19, 2022

Study Record Updates

Last Update Posted (Actual)

February 15, 2023

Last Update Submitted That Met QC Criteria

February 14, 2023

Last Verified

February 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • Bruyere

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rehabilitation

Clinical Trials on Motivating reminiscence physical therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe